Financial Information | Regeneron Pharmaceuticals Inc.

Filing date	Form	Description	View
Nov 19, 2002	424B3	Form of prospectus reflecting facts events constituting substantive change from last form	View HTML 0000950123-02-011130.pdf
Nov 12, 2002	10-Q	Quarterly report which provides a continuing view of a company's financial position	View HTML 0000950123-02-010532.pdf 0000950123-02-010532.xls
Sep 04, 2002	SC 13G/A	An amendment to the SC 13G filing	View HTML 0001015402-02-003064.pdf
Aug 13, 2002	10-Q	Quarterly report which provides a continuing view of a company's financial position	View HTML 0000950123-02-007796.pdf 0000950123-02-007796.xls
Jul 30, 2002	S-8 POS	Post-effective amendment to an S-8 filing	View HTML 0000950123-02-007336.pdf
Jul 30, 2002	S-8	Securities offered to employees pursuant to employee benefit plans	View HTML 0000950123-02-007337.pdf
Jul 25, 2002	8-K	Report of unscheduled material events or corporate event	View HTML 0000950123-02-007231.pdf
Jul 11, 2002	8-K	Report of unscheduled material events or corporate event	View HTML 0000950123-02-006929.pdf
Jul 08, 2002	8-K	Report of unscheduled material events or corporate event	View HTML 0000950123-02-006802.pdf
May 15, 2002	424B3	Form of prospectus reflecting facts events constituting substantive change from last form	View HTML 0000950123-02-005298.pdf

Data provided by Kaleidoscope.

Investors & Media